HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tomoki Omodani Selected Research

N- ((3- (carboxymethyl)- 2- oxoimidazolidin- 1- yl)acetyl)- l- valyl- N- ((3S)- 1,1,1- trifluoro- 4- methyl- 2- oxopentan- 3- yl)- l- prolinamide

11/2009Development of a highly water-soluble peptide-based human neutrophil elastase inhibitor; AE-3763 for treatment of acute organ injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tomoki Omodani Research Topics

Disease

1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
11/2009
1Chronic Obstructive Pulmonary Disease (COPD)
11/2009
1Lung Injury
11/2009
1Acute Lung Injury
11/2009
1Hemorrhage
11/2009
1Respiratory Insufficiency (Respiratory Failure)
02/2002

Drug/Important Bio-Agent (IBA)

1N- ((3- (carboxymethyl)- 2- oxoimidazolidin- 1- yl)acetyl)- l- valyl- N- ((3S)- 1,1,1- trifluoro- 4- methyl- 2- oxopentan- 3- yl)- l- prolinamideIBA
11/2009
1GalactosamineIBA
11/2009
1LipopolysaccharidesIBA
11/2009
1Pancreatic Elastase (Elastase)IBA
11/2009
1Carboxylic AcidsIBA
02/2002
1Peptides (Polypeptides)IBA
02/2002
1Leukocyte Elastase (Neutrophil Elastase)IBA
02/2002